CLINICAL_TRIALS
trial_result
· 2011-03-23
Clinical Trial Update: The Effects of LAF237 on Gastric Function in Type 2 Diabetes [Phase 3]
Summary
A completed Phase 3 clinical trial evaluated the effects of LAF237 on gastric function in adults with type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Phase 3 | Status: COMPLETED